LifeSiteNews.com Life, Family and Culture News

Email: "Pharmaceutical Profits behind Rejection of Abortion Breast Cancer Link"

Your Email:

Your Name:

Send To Email:

Subject:

Message:
BY LifeSiteNews.com DAVENPORT, Iowa, June 2, 2004 (LifeSiteNews.com) - At a recent conference on the link between abortion and breast cancer, Karen Malec, of the Coalition on Abortion/Breast Cancer, argued that drug-profit financed research, such as a recent Lancet study, is a conflict of interest. “The American Association of Obstetricians and Gynecologists and many cancer fundraising groups and major U.S. cancer research centers are funded by self-interested pharmaceutical companies that manufacture cancer drugs and hormonal contraceptives,” she argued. Malec explained that the Coalition on Abortion/Breast Cancer has nothing to gain by exposing the link between abortion and breast cancer. “On the other hand, much has been written about the corruption of scientific research by corporate interests,” she continued. “Governments that have pursued an aggressive population control agenda during the last thirty years, have a good reason to continue the 47-year cover-up of the ABC link. Once women learn they’ve been used in a massive experiment as human guinea pigs, many politicians will pay a high political price when voters go to the polls.”  In related news, a woman breast cancer patient returned a wig donated to her by the Susan G. Komen Breast CancerFoundation. At a celebrity press conference, the Komen foundation had expected her to say a few words - instead, Joan Archer returned the wig, and condemned the foundation for its support of Planned Parenthood. Archer cited the connection between abortion and breast cancer as the reason for her disappointment.  Judy McFarlin, a spokesman for the Komen-supported initiative, Race for the Cure,  reacted to Archer’s accusation of a link between abortion and breast cancer. “At this point in time we have not received any documented information,” she said.  Read the related LifeSiteNews.com coverage:  Read the Catholic Standard & Times report about the Brind/Lanfranchi conference at:  http://www.cst-phl.com/fifth.html   Visit the Coalition on Abortion/Breast Cancer web-site at:  www.AbortionBreastCancer.com http://www.lifesitenews.com/news/pharmaceutical-profits-behind-rejection-of-abortion-breast-cancer-link/

Please enter the word you see in the image below: